Items where authors include "Spiller, R"

Article

Gunn, D, Topan, R, Barnard, L orcid.org/0000-0001-5436-6882 et al. (19 more authors) (2023) Randomised, placebo-controlled trial and meta-analysis show benefit of ondansetron for irritable bowel syndrome with diarrhoea: The TRITON trial. Alimentary Pharmacology & Therapeutics, 57 (11). pp. 1258-1271. ISSN 0269-2813

Fritz, N, Berens, S, Dong, Y et al. (52 more authors) (2022) The serotonin receptor 3E variant is a risk factor for female IBS-D. Journal of Molecular Medicine, 100 (11). pp. 1617-1627. ISSN 0946-2716

Eijsbouts, C, Zheng, T, Kennedy, NA et al. (28 more authors) (2021) Genome-wide analysis of 53,400 people with irritable bowel syndrome highlights shared genetic pathways with mood and anxiety disorders. Nature Genetics, 53 (11). pp. 1543-1552. ISSN 1061-4036

Mohr, S, Fritz, N, Hammer, C et al. (53 more authors) (2021) The alternative serotonin transporter promoter P2 impacts gene function in females with irritable bowel syndrome. Journal of Cellular and Molecular Medicine, 25 (16). pp. 8047-8061. ISSN 1582-1838

Gunn, D, Fried, R, Lalani, R et al. (22 more authors) (2019) Treatment of irritable bowel syndrome with diarrhoea using titrated ondansetron (TRITON): study protocol for a randomised controlled trial. Trials, 20. 517. ISSN 1745-6215

Proceedings Paper

Niesler, B, Hattensperger, N, Martinez, C et al. (43 more authors) (2018) The Serotonin receptor 3E subunit variant HTR3E c.*76G> A is confirmed as a risk factor for IBS- D in females. In: Neurogastroenterology and Motility. FNM 2018 – 3rd Meeting of the Federation of Neurogastroenterology and Motility, 29 Aug - 01 Sep 2018, Amsterdam, The Netherlands. Wiley .